Gonoccocal resistance to antimicrobials surveillance programme (GRASP) action plan for England and Wales: informing the Public Health Response
Health Protection Agency
- Public health control of gonorrhoea is dependent of the provision of effective antimicrobial therapy and has been compromised by resistance to successive therapeutic agents over decades.
- Surveillance data has shown a drift towards decreased susceptibility to the third generation cephalosporins currently recommended for therapy — ceftriaxone and cefixime.
- Therapeutic failure to ceftriaxone and cefixime is still rare but is documented.
- The WHO Global Action Plan and ECDC Response Plan have been published to provide strategic advice on the threat of MDR gonorrhoea.
- National guidelines have been published in response to this threat and TOC is recommended.
- The GRASP Action plan aims to raise awareness and provide advice on the international problem of antimicrobial resistant gonorrhoea. Case definitions have been recommended for confirmed and probable treatment failure.
Free PDF only
For further information please visit the GRASP page.
Last reviewed: 26 February 2013